217 related articles for article (PubMed ID: 38190411)
1. Mutations accumulated in the Spike of SARS-CoV-2 Omicron allow for more efficient counteraction of the restriction factor BST2/Tetherin.
Shi Y; Simpson S; Chen Y; Aull H; Benjamin J; Serra-Moreno R
PLoS Pathog; 2024 Jan; 20(1):e1011912. PubMed ID: 38190411
[TBL] [Abstract][Full Text] [Related]
2. Tetherin Restricts SARS-CoV-2 despite the Presence of Multiple Viral Antagonists.
Hagelauer E; Lotke R; Kmiec D; Hu D; Hohner M; Stopper S; Nchioua R; Kirchhoff F; Sauter D; Schindler M
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140605
[TBL] [Abstract][Full Text] [Related]
3. Severe acute respiratory syndrome coronavirus spike protein counteracts BST2-mediated restriction of virus-like particle release.
Wang SM; Huang KJ; Wang CT
J Med Virol; 2019 Oct; 91(10):1743-1750. PubMed ID: 31199522
[TBL] [Abstract][Full Text] [Related]
4. Tetherin antagonism by SARS-CoV-2 ORF3a and spike protein enhances virus release.
Stewart H; Palmulli R; Johansen KH; McGovern N; Shehata OM; Carnell GW; Jackson HK; Lee JS; Brown JC; Burgoyne T; Heeney JL; Okkenhaug K; Firth AE; Peden AA; Edgar JR
EMBO Rep; 2023 Dec; 24(12):e57224. PubMed ID: 37818801
[TBL] [Abstract][Full Text] [Related]
5. Computational modeling of the effect of five mutations on the structure of the ACE2 receptor and their correlation with infectivity and virulence of some emerged variants of SARS-CoV-2 suggests mechanisms of binding affinity dysregulation.
Rodriguez JA; Gonzalez J; Arboleda-Bustos CE; Mendoza N; Martinez C; Pinzon A
Chem Biol Interact; 2022 Dec; 368():110244. PubMed ID: 36336003
[TBL] [Abstract][Full Text] [Related]
6. Contribution of the Cytoplasmic Determinants of Vpu to the Expansion of Virus-Containing Compartments in HIV-1-Infected Macrophages.
Leymarie O; Lepont L; Versapuech M; Judith D; Abelanet S; Janvier K; Berlioz-Torrent C
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867316
[TBL] [Abstract][Full Text] [Related]
7. Spike protein of SARS-CoV-2 Omicron variant: An
Jimenez Ruiz JA; Lopez Ramirez C; Lopez-Campos JL
Front Public Health; 2022; 10():1052241. PubMed ID: 36523581
[TBL] [Abstract][Full Text] [Related]
8. In Silico Screening of Bioactive Compounds of Representative Seaweeds to Inhibit SARS-CoV-2 ACE2-Bound Omicron B.1.1.529 Spike Protein Trimer.
Bharathi M; Sivamaruthi BS; Kesika P; Thangaleela S; Chaiyasut C
Mar Drugs; 2022 Feb; 20(2):. PubMed ID: 35200677
[TBL] [Abstract][Full Text] [Related]
9. Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants.
da Costa CHS; de Freitas CAB; Alves CN; Lameira J
Sci Rep; 2022 May; 12(1):8540. PubMed ID: 35595778
[TBL] [Abstract][Full Text] [Related]
10. A bias of Asparagine to Lysine mutations in SARS-CoV-2 outside the receptor binding domain affects protein flexibility.
Boer JC; Pan Q; Holien JK; Nguyen TB; Ascher DB; Plebanski M
Front Immunol; 2022; 13():954435. PubMed ID: 36569921
[TBL] [Abstract][Full Text] [Related]
11. ATG5 selectively engages virus-tethered BST2/tetherin in an LC3C-associated pathway.
Judith D; Versapuech M; Bejjani F; Palaric M; Verlhac P; Kuster A; Lepont L; Gallois-Montbrun S; Janvier K; Berlioz-Torrent C
Proc Natl Acad Sci U S A; 2023 May; 120(20):e2217451120. PubMed ID: 37155854
[TBL] [Abstract][Full Text] [Related]
12. BST2/CD317 counteracts human coronavirus 229E productive infection by tethering virions at the cell surface.
Wang SM; Huang KJ; Wang CT
Virology; 2014 Jan; 449():287-96. PubMed ID: 24418563
[TBL] [Abstract][Full Text] [Related]
13. Adaptive variations in SARS-CoV-2 spike proteins: effects on distinct virus-cell entry stages.
Qing E; Gallagher T
mBio; 2023 Aug; 14(4):e0017123. PubMed ID: 37382441
[TBL] [Abstract][Full Text] [Related]
14. Characterization and Function of Glycans on the Spike Proteins of SARS-CoV-2 Variants of Concern.
Zheng L; Wang K; Chen M; Qin F; Yan C; Zhang XE
Microbiol Spectr; 2022 Dec; 10(6):e0312022. PubMed ID: 36318020
[TBL] [Abstract][Full Text] [Related]
15. LC3C Contributes to Vpu-Mediated Antagonism of BST2/Tetherin Restriction on HIV-1 Release through a Non-canonical Autophagy Pathway.
Madjo U; Leymarie O; Frémont S; Kuster A; Nehlich M; Gallois-Montbrun S; Janvier K; Berlioz-Torrent C
Cell Rep; 2016 Nov; 17(9):2221-2233. PubMed ID: 27880899
[TBL] [Abstract][Full Text] [Related]
16. Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile.
Alkhatib M; Salpini R; Carioti L; Ambrosio FA; D'Anna S; Duca L; Costa G; Bellocchi MC; Piermatteo L; Artese A; Santoro MM; Alcaro S; Svicher V; Ceccherini-Silberstein F
Microbiol Spectr; 2022 Apr; 10(2):e0273221. PubMed ID: 35352942
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity.
Khatri R; Siddqui G; Sadhu S; Maithil V; Vishwakarma P; Lohiya B; Goswami A; Ahmed S; Awasthi A; Samal S
Med Microbiol Immunol; 2023 Feb; 212(1):103-122. PubMed ID: 36583790
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a mouse origin of the SARS-CoV-2 Omicron variant.
Wei C; Shan KJ; Wang W; Zhang S; Huan Q; Qian W
J Genet Genomics; 2021 Dec; 48(12):1111-1121. PubMed ID: 34954396
[TBL] [Abstract][Full Text] [Related]
19. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA
Elife; 2021 Aug; 10():. PubMed ID: 34435953
[TBL] [Abstract][Full Text] [Related]
20. Genome sequencing of SARS-CoV-2 omicron variants in Delhi reveals alterations in immunogenic regions in spike glycoprotein.
Shikha S; Jogi MK; Jha R; Kumar RA; Sah T; Singh P; Sagar R; Kumar A; Marwal R; Ponnusamy K; Agarwal SM; Kumar RS; Arif N; Bharadwaj M; Singh S; Kumar P
Front Immunol; 2023; 14():1209513. PubMed ID: 37849762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
